This inventor holds 3 USPTO granted patents and 6 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignees: Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd., Taizhou Fudan-Zhangjiang Pharmaceutical Co., Ltd.. Active years: 2013-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 4 
1 out of 1 Years Active: 2013-2025
Title: The Innovative Contributions of Fang Wu
Introduction
Fang Wu is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of biopharmaceuticals, particularly in the development of antibodies for cancer treatment. With a total of 3 patents, his work focuses on innovative solutions that target tumor cells effectively.
Latest Patents
Fang Wu's latest patents include groundbreaking advancements in antibody technology. One of his notable inventions is the "Anti-B7-H3 antibody, preparation method therefor, conjugate and application thereof." This fully human antibody is designed to specifically bind to the B7-H3 antigen on tumor cells, facilitating rapid internalization into these cells. This characteristic enhances its potential for use in antibody-drug conjugate (ADC) drug development, aiming to improve anti-tumor activity and efficacy in cancer treatment.
Another significant patent is the "Antibody-drug conjugate, and intermediate thereof, preparation method therefor, and application thereof." This invention represents an antibody-drug conjugate that exhibits excellent targetability and inhibitory effects on HER3-positive tumor cells. The compound demonstrates high safety and druggability, making it a promising candidate for further research and development in oncology.
Career Highlights
Fang Wu has worked with notable companies in the biopharmaceutical sector, including Shanghai Fudan-Zhangjiang Bio-pharmaceutical Co., Ltd. and Taizhou Fudan-Zhangjiang Pharmaceutical Co., Ltd. His experience in these organizations has contributed to his expertise in developing innovative therapeutic solutions.
Collaborations
Fang Wu has collaborated with talented individuals in his field, including Tong Yang and Yijun Shen. Their combined efforts have fostered advancements in biopharmaceutical research and development.
Conclusion
Fang Wu's contributions to the field of biopharmaceuticals through his innovative patents and collaborations highlight his commitment to advancing cancer treatment. His work continues to pave the way for new therapeutic options that can significantly impact patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile